Luca Cefalù
5.0
(8)
Studied at Bocconi University
Works at Merrill Lynch
Successful clients at
Not currently taking new clients
Work Experience
Investment Banking Associate
Merrill Lynch
July 2025 - Present
- Sale of Lonza's Capsule and Health Ingredients division to Lone Star Funds at a $3bn valuation (2026) - Best efforts re-financing of SHL Medical's debt facilities (2026) - Intas Pharma / Accord Healthcare acquisition of Prothya Biosolutions (2025) - Lonza $1.2bn acquisition of a large-scale biologics site from Roche (2024) - Financing for CD&R €16bn acquisition of a 50% stake in Sanofi’s Consumer Healthcare division (2024)
Member
NOVA
March 2025 - Present
Investment Banking Analyst
Merrill Lynch
July 2023 - June 2025
Healthcare
Summer Investment Banking Analyst
Merrill Lynch
June 2022 - August 2022
Healthcare, TMT, Consumer & Retail
Audit & Assurance Intern
PwC
March 2021 - May 2021
Luca was also given offers to work at
PJT Partners
CPP Investments
Education
Nova School of Business and Economics
MSc in Finance
2022 - 2023
Double Degree (Host University)
Bocconi University
MSc in Finance
2021 - 2023
Double Degree (Home University)
Bocconi University
BSc, Economics and Finance
2018 - 2021
Luca was also personally admitted to
Free International University of Social Studies
8 Reviews
Overall Rating
5.0
Luca has helped Leland clients get into University of Bologna
Luca has helped Leland clients get into Bank of America